Purchase Order 75N91019P00734

<p>The National Cancer Institute issued a purchase order to Analogic Corp on December 5, 2017, for maintenance services on a BK-3000 ultrasound system, with a ceiling value of $69,853.05 and firm fixed price. No set-aside category applied. Place of performance is Bethesda, Maryland. The order was executed to de-obligate expiring FY2019 funds following NIH Office of Administration and Management Communications 24-16, with an ultimate completion date of December 27, 2024.</p>

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC on June 7, 2018, with a ceiling value of $4,300.08 and ultimate completion date of June 14, 2019. The order is priced as firm fixed price with no set-aside. Place of performance is Marlborough, Massachusetts. The specific procurement details and commodity description are not provided in the source material.</p>

The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $13,950 purchase order to Intera Oncology Inc. for laboratory equipment. The firm fixed price contract has a period of performance from September 6, 2023 through October 28, 2023 and will be performed in Wellesley Hills, Massachusetts. No additional details were provided regarding the specific laboratory equipment being procured. The National Cancer Institute conducts and supports...

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $12,768.84 on September 11, 2018, with completion scheduled for September 18, 2019. Pricing is fixed-price with economic price adjustment. Place of performance is Bethesda, Maryland. The source does not identify the specific items or services procured under this order.</p>

<p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $14,955.00 on September 3, 2019, for lab equipment. The order carries no set-aside designation. Performance is located in Lawrence, Massachusetts, with an ultimate completion date of September 30, 2019. The purchase order is priced on a firm fixed price basis for commercial laboratory equipment, including cell analysis and imaging cytometry products used in biomedical research.</p>

<p>The National Cancer Institute awarded a purchase order to Northeastern University valued at $19,345.00 on May 15, 2020, for professional services. Place of performance is Bethesda, Maryland. The order carries a firm fixed-price structure with an ultimate completion date of December 31, 2020. No set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Noldus Information Technology, Inc. for $14,797.00 on September 8, 2017, with ultimate completion on September 7, 2018. Performance occurs in Bethesda, Maryland. The order is fixed-price with economic price adjustment and carries no small business set-aside. The source does not specify the particular equipment, software, or services procured under this order.</p>

The National Cancer Institute issued a purchase order to Coherent Inc. on June 30, 2021, valued at $14,751.77, for maintenance agreement services with an ultimate completion date of July 24, 2022. The order represents a firm fixed-price acquisition to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of fund availability. Performance occurs in Bethesda, Maryland. No small business...

<p>The National Cancer Institute awarded a purchase order to Global Life Sciences Solutions USA LLC for $97,997.20 on April 4, 2017, for maintenance services for a Delta Vision OMX instrument. The order is firm fixed price with no small business set-aside. Place of performance is Marlborough, Massachusetts. The ultimate completion date is April 3, 2022.</p>

<p>The National Cancer Institute awarded a purchase order to Nexcelom Bioscience LLC for $12,180.00 on August 2, 2018. No set-aside was applied. The order is for lab equipment with a firm fixed price and ultimate completion date of September 28, 2018. Place of performance is Lawrence, Massachusetts.</p>